OCT4 is superior to CD30 in the diagnosis of metastatic embryonal carcinomas after chemotherapy (Q83868301)
Jump to navigation
Jump to search
scientific article published on 01 June 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | OCT4 is superior to CD30 in the diagnosis of metastatic embryonal carcinomas after chemotherapy |
scientific article published on 01 June 2006 |
Statements
OCT4 is superior to CD30 in the diagnosis of metastatic embryonal carcinomas after chemotherapy (English)
Ming-Tse Sung
Timothy D Jones
Stephen D Beck
Richard S Foster